» Articles » PMID: 39223206

A Composite Patch Loaded with 2-Deoxy Glucose Facilitates Cardiac Recovery After Myocardial Infarction Via Attenuating Local Inflammatory Response

Overview
Journal Sci Rep
Specialty Science
Date 2024 Sep 2
PMID 39223206
Authors
Affiliations
Soon will be listed here.
Abstract

Local inflammatory microenvironment in the early stage of myocardial infarction (MI) severely impaired cardiac recovery post-MI. Macrophages play a pivotal role in this process. A classical glycolytic inhibitor, 2-Deoxy-Glucose (2-DG), has been found to regulate the excessive pro-inflammatory macrophage polarization in the infarcted myocardium. This study investigated the effect of 2-DG-loaded chitosan/gelatin composite patch on the infarct microenvironment post-MI and its impact on cardiac repair. The results showed that the 2-DG patch significantly inhibited the expression of inflammatory cytokines, alleviated reactive oxygen species (ROS) accumulation, repressed the proinflammatory polarization of macrophages, attenuated local inflammatory microenvironment in the ischemic hearts, as well as improved cardiac function, reduced scar size, and promoted angiogenesis post-MI. In terms of mechanism, 2-DG exerts anti-inflammatory effects through inhibiting the NF-κB signaling pathway and reducing the assembly and activation of the NLRP3 inflammasome. These findings suggest that 2-DG composite patch may represent a promising therapeutic strategy for cardiac repair after MI.

Citing Articles

Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment.

Zhang W, Peng D, Cheng S, Ni R, Yang M, Cai Y Bioengineering (Basel). 2025; 12(2).

PMID: 40001724 PMC: 11852162. DOI: 10.3390/bioengineering12020205.


Mitochondria-Targeted Biomaterials-Regulating Macrophage Polarization Opens New Perspectives for Disease Treatment.

Tian Z, Wang X, Chen S, Guo Z, Di J, Xiang C Int J Nanomedicine. 2025; 20:1509-1528.

PMID: 39925677 PMC: 11806677. DOI: 10.2147/IJN.S505591.


Targeting Lactic Acid Modification in Ischemic Heart Diseases: Novel Therapeutics and Mechanism.

Wan T, Liang Y, Wei T, Chen Z, Li Y J Cardiovasc Transl Res. 2025; .

PMID: 39920549 DOI: 10.1007/s12265-025-10593-3.

References
1.
Ong S, Hernandez-Resendiz S, Crespo-Avilan G, Mukhametshina R, Kwek X, Cabrera-Fuentes H . Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018; 186:73-87. PMC: 5981007. DOI: 10.1016/j.pharmthera.2018.01.001. View

2.
Reed G, Rossi J, Cannon C . Acute myocardial infarction. Lancet. 2016; 389(10065):197-210. DOI: 10.1016/S0140-6736(16)30677-8. View

3.
Saito Y, Oyama K, Tsujita K, Yasuda S, Kobayashi Y . Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. J Cardiol. 2022; 81(2):168-178. DOI: 10.1016/j.jjcc.2022.07.003. View

4.
Raez L, Papadopoulos K, Ricart A, Chiorean E, DiPaola R, Stein M . A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2012; 71(2):523-30. DOI: 10.1007/s00280-012-2045-1. View

5.
Zhong W, Yang H, Guan X, Xiong J, Sun C, Zhang C . Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model. J Cell Physiol. 2018; 234(4):4641-4654. DOI: 10.1002/jcp.27261. View